Latest HPV vaccine Stories

AUSTIN, Texas, March 26, 2012 /PRNewswire-USNewswire/ -- Nobel Prize winner Harald zur Hausen called for vaccinating both young males and females for human papilloma virus (HPV) in an achievable quest to eradicate cervical cancer, which is the second leading type of women's cancer worldwide. Zur Hausen made his remarks at a gathering of more than 1,600 members of the Society of Gynecologic Oncology during its 43rd Annual Meeting on Women's Cancer®( )in Austin. "If we wish to...

Women ages 21 to 65 should have a Pap smear every three years, according to new guidelines from the United States Preventive Services Task Force (USPSTF). Based on the evidence, women between the ages of 30 and 65 can safely extend the screening interval to once every five years if they undergo the humanpapillomavirus (HPV) test at the same time as the Pap. The guideline is being published early online in Annals of Internal Medicine. The USPSTF recommends against screening for cervical...

Researchers from Boston University School of Medicine (BUSM) have found that a health care provider's attitude toward male human papillomavirus (HPV) vaccination may influence the implementation of new guidelines. They believe targeted provider education on the benefits of HPV vaccination for male patients, specifically the association of HPV with certain cancers in men, may be important for achieving vaccination goals. These findings appear on-line in the American Journal of Men's Health....

A study of cervical cancer incidence and mortality in North Carolina has revealed areas where rates are unusually high. The findings indicate that education, screening, and vaccination programs in those places could be particularly useful, according to public health researchers at the University of North Carolina at Chapel Hill, who authored the report. “In general the rates of incidence and mortality in North Carolina are consistent with national averages,” said Jennifer S. Smith,...

After last year’s heated political rows over mandating vaccinations for human papillomavirus (HPV) in teenage girls, the American Academy of Pediatrics (AAP) has announced that it now also supports vaccinations for boys as well. According to Monday’s online version of the AAP’s publication Pediatrics, boys aged 11 and 12 should receive three routine immunizations against HPV, a revision of the organization’s previous stance on the issue which it had termed a “permissive...

The Centers for Disease Control and Prevention (CDC) said in a recent report that it recommends all males between the ages 11 and 21 get the human papillomavirus (HPV) vaccine to protect against diseases and cancers. The CDC's Advisory Committee on Immunization Practices said it recommends the HPV vaccine be routine for all boys. According to the report, at least 50 percent of sexually active men and women get infected with HPV at some point, but few develop symptoms or get sick....

The CDC's Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule being published February 1 in Annals of Internal Medicine (www.annals.org), the flagship journal of the American College of Physicians (ACP). In addition to the changes in the HPV vaccine, the ACIP now recommends vaccination...

According to a new study, oral infections with the human papillomavirus (HPV) are more common in men than women. The study, published in the Journal of the American Medical Association, said that while the viruses can be found in saliva, HPV appears to be mostly spread through sex. Study author Maura Gillison, a professor at the Ohio State University Comprehensive Cancer Center said the virus can cause cancers at the back of the throat, tonsils and base of the tongue.  Patients...

Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Human papillomavirus, or HPV, has recently been linked to some types of head and neck cancer that are becoming more prominent in the United States, mostly among men. Patients infected with oral HPV type 16 have a 14...

The overall prevalence of oral human papillomavirus (HPV) infection is approximately 7 percent among men and women ages 14 to 69 years in the United States, while the prevalence among men is higher than among women, according to a study appearing in JAMA. The study is being released early online to coincide with its presentation at the Multidisciplinary Head and Neck Cancer Symposium. "Oral HPV infection is the cause of a subset of oropharyngeal [relating to the mouth and pharynx] squamous...